Gene basic information

symbol AGAP2-AS1
name AGAP2 antisense RNA 1
location 12q14.1
alias_symbol LOC100130776|PUNISHER
Cancernon-small-cell lung cancer,


LncRNA AGAP2-AS1 is up-regulated in non-small cell lung cancer (NSCLC), and correlated with tumor size, advanced pathological stage and poor prognosis. AGAP2-AS1 can increase NSCLC cell proliferation, migration and invasion, but inhibit NSCLC cell apoptosis. Mechanistically, AGAP2-AS1 can repress LATS2 and KLF2 transcription via binding with EZH2 and LSD1 (1).

Cancer related information

download as excel csv txt

LncRNA tissue cancer type expression level oncogene/suppress gene pathway binding gene/factor associated gene/factor proliferation apoptosis migration EMT invasion metastasis prognosis tag PMID
0 AGAP2-AS1 lung non-small-cell lung cancer up onco EZH2,lysine (K)-specific demethylase 1A (LSD1) LATS2-,KLF2- + - + + + - 27195672

Expression profile

adipose adrenal brain breast colon heart kidney leukocyte liver lung lymph node ovary prostate skeletal muscle testis thyroid tissue 0 1 2 3 4 5 6 fpkm 6.0 5.0 0.4 2.0 2.0 0.5 0.9 0.0 0.3 1.0 4.0 4.0 2.0 0.4 2.0 0.9 AGAP2-AS1

Expression profile in human body map

Genomic feature visualization


External link


[1]. Li W, Sun M, Zang C, Ma P, He J, et al. (2016). Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells. Cell Death Dis 7: e2225. link pubmed

© Bioinformatics Group of XTBG